Assessment of Safety and Performances of HYPE Stems Associated to a SERF Acetabular Cup in Hip Arthroplasty (2017-01-NH)
NCT ID: NCT05524350
Last Updated: 2025-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
180 participants
OBSERVATIONAL
2017-12-05
2031-01-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study will validate the performance and safety of the HYPE (SERF) stems in the context of the 93/42/EEC directive and in relation to the recommendations of the MEDDEV 2.7.1 (Guideline for post-marketing follow-up), which provides for a systematic procedure for monitoring clinical data in order to verify the performance claimed for medical devices.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective and Obsevational Study of Total Hip Prothesis: HYPE Stem
NCT05560022
Assessment of Safety and Performances of HYPE SCS Stem Associated to NOVAE Sunfit TH Acetabular Cup in Hip Arthroplasty
NCT05524363
Exception Cementless Hip Stem
NCT04349046
Avenir® Cemented Hip Stem - PMCF
NCT03396224
Observational Ambispective Study on HYPE Cups Associated With HIPER Liner
NCT06465940
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Degenerative or inflammatory hip disease requiring total hip replacement
* Primary or secondary osteoarthritis,
* Advanced joint destruction resulting from rheumatoid arthritis or traumatic origin,
* Avascular fracture or necrosis,
* Displaced subcapital and transcervical fracture as well as PAPROSKY stages I to IIB bone defects.
* Joint destruction of traumatic origin
* Following a previous operation, provided that the new device does not interfere with the material in place (osteosynthesis, joint reconstruction, arthrodesis, hemiarthroplasty, total arthroplasty).
Exclusion Criteria
* Known pregnancy in progress
* Breastfeeding
* Patient requiring a bone graft
* Neurological disorders or other pathology that may influence locomotion
* History of sepsis in the hip to be operated on
* Short-term vital prognosis
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Societe dEtude, de Recherche et de Fabrication
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rouen University Hospital Center
Rouen, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A03359-44
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.